12-17-2020, 03:30 PM
Here's the article in question.
https://www.nytimes.com/2020/12/16/healt...ction.html
I feel that the article does a decent job of offering context. On some of the specific concerns:
and later
As for the issue of not providing a denominator...
BC
https://www.nytimes.com/2020/12/16/healt...ction.html
I feel that the article does a decent job of offering context. On some of the specific concerns:
Quote:The hospital, which had administered 144 total doses as of Wednesday night, said both workers did not want their experiences to have a negative impact on others lining up for the vaccine.
“We have no plans to change our vaccine schedule, dosing or regimen,” Dr. Anne Zink, Alaska’s chief medical officer, said in a statement.
Although the Pfizer vaccine was shown to be safe and about 95 percent effective in a clinical trial involving 44,000 participants, the Alaska cases will likely intensify concerns about possible side effects. Experts said the developments may prompt calls for tighter guidelines to ensure that recipients were carefully monitored for adverse reactions.
Dr. Paul A. Offit, a vaccine expert and member of an outside advisory panel that recommended the Food and Drug Administration authorize the Pfizer vaccine for emergency use, said the appropriate precautions were already in place. For instance, he said, the requirement that recipients remain in place for 15 minutes after getting the vaccine helped ensure the woman was quickly treated.
and later
Quote:Dr. Jay Butler, a top infectious-disease expert with the Centers for Disease Control and Prevention, said the Alaska situation showed that the monitoring system worked. The agency has recommended that the vaccine be administered in settings that have supplies, including oxygen and epinephrine, to manage anaphylactic reactions.
As for the issue of not providing a denominator...
Quote:As of Wednesday night, it was unclear how many Americans so far have received it.
BC
